Ent Devices Industry Overview

The global ENT devices market size is anticipated to reach USD 37.72 billion by 2030, growing at a CAGR of 5.54% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth can be attributed to factors such as a rising geriatric population, high prevalence of hearing loss, and increasing penetration of minimally invasive surgeries. Technological advancements in this field, an increase in healthcare investment for early detection of diseases, and favorable regulatory policies are other factors expected to drive the market’s growth.

The risk of poor immunity increases with age, making older people more vulnerable to disorders of the nose and throat. To address this issue, elderly people need regular check-ups for ENT disorders, which is leading to a rise in demand for ENT devices. According to the Royal National Institute for Deaf People (RNID), over 12 million people in the UK suffered from hearing loss. Out of these, over 40% of people were in the 50s above, and more than 70% of people were in the 70s above.

Gather more insights about the market drivers, restrains and growth of the Ent Devices Market

Hearing loss is a common chronic physical condition affecting the people of all ages. It is the third-most common condition after high blood pressure and arthritis. It is more prevalent in elder population, particularly in people over 65 years of age, and 1 in 3 people are likely to suffer from a disabling hearing loss. It can negatively impact communication and leading to depression, anxiety, social isolation, and cognitive decline. According to the National Institute on Deafness and Other Communication Disorders, 15% of the total U.S. population over 18 years of age are likely to have a hearing impairment. In addition, men are more likely to be affected with hearing loss than women.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global dental protein combined products market size was estimated at USD 1.02 billion in 2024 and is projected to grow at a CAGR of 10.0% from 2025 to 2030.
  
  
• The global ophthalmic loupes market size was estimated at USD 542.7 million in 2024 and is projected to grow at a CAGR of 7.6% from 2025 to 2030.

ENT Devices Market Segmentation

Grand View Research has segmented the global ENT devices market based on product and region:

ENT Devices Product Outlook (Revenue, USD Million, 2018 - 2030)

• Diagnostic ENT Devices
  • Rigid Endoscopes
    • Sinuscopes
    • Otoscopes
    • Laryngoscopes
  • Flexible Endoscopes
    • Bronchoscopes
    • Laryngoscopes
    • Nasopharyngoscopes
  • Robot Assisted Endoscope
  • Hearing Screening Device
• Surgical ENT Devices
  • Radiofrequency handpieces
  • Otological Drill Burrs
  • ENT Hand Instruments
  • Sinus Dilation Devices
  • Nasal Packing Devices
• Hearing Aids
• Hearing Implants
• Nasal Splints

ENT Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

 Key Companies profiled:

• Ambu A/S
• Cochlear Ltd.
• Demant A/S
• GN Store Nord A/S
• Karl Storz
• Olympus Corporation
• PENTAX Medical
• Richard Wolf GmbH
• Rion Co., Ltd.
• Smith Nephew plc
• Sonova

Key ENT Devices Company Insights

Some of the key market players include, Cochlear Ltd., Demant A/S, Stryker, and KARL STORZ.

• Cochlear Ltd. (Cochlear) engages in developing and commercializing cochlear implants, bone conduction implants, acoustic implants to treat hearing-impaired individuals. Cochlear Ltd. is a global company with major manufacturing facilities in Sweden and Australia.It has a global presence in more than 180 countries.
• Demant A/S (Demant) is a global company that develops, manufactures, and commercializes hearing implants, traditional hearing instruments, personal communication devices, diagnostic instruments. The group operates in over 30 countries and sells its products in over 130 countries.

Recent Developments

• In April 2023, Unitron, a brand of Sonova launched Vivante, a platform aimed to enhance listener’s experience through personalized hearing control. This platform offers improved sound performance and new designs to enhance the hearing experience, integrating experience innovations and the remote plus app to offer a customized hearing experience.
• In February 2023, Cochlear Ltd. announced a partnership with Amazon.com, Inc. to expand audio streaming for hearing aids for people with Cochlear's hearing implants to provide comfortable entertainment.
• In November 2022, Cochlear Ltd. announced the expansion of its manufacturing facility plant in Kuala Lumpur, Malaysia. The expansion involved an asset of more than USD 6.28 million (RM 30 million) to help the growing demand for acoustic and cochlear hearing implants.

Order a free sample PDF of the Ent Devices Market Intelligence Study, published by Grand View Research.